查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844167

心臟假体设备市场按产品类型、手术方法、材料类型、最终用户和适应症划分－2025-2032 年全球预测

Cardiac Prosthetic Devices Market by Product Type, Procedure Approach, Material Type, End User, Indication - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年心臟假体设备市场规模将成长至 332.4 亿美元，复合年增长率为 16.22%。

主要市场统计数据
基准年2024年 99.8亿美元
预计2025年 115.7亿美元
预测年份：2032年 332.4亿美元
复合年增长率（%） 16.22%

权威介绍设备设计创新、临床实践转变和不断变化的监管期望如何重新定义心臟假体设备策略

心臟假体装置领域正处于先进生物医学工程、不断发展的临床实践和日新月异的医疗经济的动态交汇点。过去十年，医疗专业人员和设备製造商已不再局限于逐步的改进，而是追求集机械可靠性、生物相容性材料和手术多功能性于一体的整合解决方案。这一发展反映了临床医生对能够降低手术全期风险、缩短康復时间并改善日益复杂的患者群体长期功能预后的设备日益增长的需求。

同时，监管审查的加强和付款人期望的提高，迫使製造商提供强有力的真实世界证据，并向医院和心臟中心展示清晰的价值提案。供应链的复杂性和零件的专业化程度不断提高，带来了新的采购和製造考量，迫使目标商标产品製造商重新思考供应商关係和垂直能力。因此，经营团队之间的策略讨论已变得司空见惯，不仅涵盖产品设计，还涵盖证据生成、服务模式和生命週期经济效益。

展望未来，差异化机会可能集中在融合创新上，例如微型电子设备、先进的聚合物和组织解决方案、更佳的设备耐用性以及可实现微创介入的手术方法。相关人员若能将临床证据计画、监管途径和商业化策略协调一致，将最有可能将科学前景转化为持续的临床应用和长期的商业性成功。

前瞻性地综合了正在重塑心臟假体设备生态系统的根本程序创新、材料进步和商业性调整

心臟假体领域正在经历一系列变革，重塑竞争优势和临床实践。在导管输送系统和影像技术进步的推动下，经导管技术正在拓展先前仅透过开胸心臟手术即可解决的适应症，并使其能够治疗高风险患者。同时，设备小型化以及将感测和连接技术整合到植入式平台，正在实现远端监控、自适应治疗流程，并与基于价值的医疗模式更紧密地整合。

材料科学带来了更持久的生物和合成材料，可降低血栓形成风险并改善动态。而积层製造和精密加工等製造创新则使更复杂的几何形状和客製化的设备尺寸成为可能。医疗保健系统越来越关注医疗总成本，推动强调手术效率、缩短住院时间和降低併发症发生率的设备策略。最后，资料共用计画和风险共担协议正在加速证据产生和报销协调，设备公司、临床中心和付款人之间的合作模式也日益普及。

这些转变虽然在不同地区和临床环境中存在差异，但却提高了参与企业和现有企业的门槛。成功的关键在于将临床、监管和商业等要素整合成一个连贯的项目，从而在实际临床环境中证明其对患者的益处和经济合理性。

深入分析不断变化的美国贸易措施如何重塑整个心臟假体供应链的采购、製造足迹和临床可及性

美国近期政策调整引发的贸易措施不断演变，正在对心臟假体设备的采购、製造和临床供应链产生一系列累积效应。直接影响是某些进口零件的到岸成本上升，促使设备製造商和经销商重新评估供应商合约和库存策略。为此，许多公司正在加速供应商多元化、双重筹资策略和区域库存缓衝，以保障手术室的正常运营，并降低单一来源中断的风险。

除了短期价格压力外，这些贸易动态也影响製造地和资本配置的策略决策。一些製造商正在评估近岸外包方案或增加对国内产能的投资，以降低关税风险并缩短关键零件的前置作业时间。此类转变不仅会影响成本结构和单位经济效益，也为韧性带来潜在益处，而韧性对于维持临床供应的连续性至关重要。

在选择供应商时，临床医生和医院采购团队越来越关注医疗总成本，而不仅仅是单价，他们会考虑设备的可靠性、服务覆盖范围和诊疗流程。监管机构和付款方正在密切关注这些变化，因为供应链重组可能会影响设备的可用性和医疗服务的连续性。最终，随着贸易政策的演变，相关人员积极模拟资费驱动情景、与供应商合作控製成本并与医疗保健系统进行有效沟通的利益相关者，将更有能力保护净利率和患者可及性。

全面的细分洞察揭示了产品类型、程序方法、材料选择、最终用户需求和临床适应症如何相互交织，从而形成商业和临床策略

细緻的细分揭示了临床需求、手术偏好和材料科学如何融合，从而推动差异化商机。以产品类型来看，植入式心臟整流去颤器市场包含不同的子类别，例如双腔、单腔和皮下系统，每种系统都有其独特的临床用例和技术要求。左心室辅助装置分为耐用型和临时型，反映了不同的患者群体和服务模式。心律调节器包括双心室、双腔和单腔设计，起搏方式和编程复杂性会影响后续护理和远端监控的需求。人工瓣膜分为生物瓣膜和机械瓣膜，其中生物瓣膜分为同种异体移植瓣膜和异种移植瓣膜，机械瓣膜分为双侧瓣膜和倾斜瓣膜设计。

当需要解剖学考虑或进行复杂修復时，开胸手术仍然很重要，而微创手术和传统胸骨切开术等手术变体正在影响医院资源的利用率。经导管手术，包括主动脉瓣和二尖瓣置换术，正在扩大老年和高风险患者的治疗范围，从而推动导管设计和影像引导方面的投资。材料类型仍然是决定性因素，生物假体选项可提供良好的血流动力学和生物整合性，而机械选项则可提供长期耐用性。在这些类别中，同种异体移植与异质骨移植、双瓣膜与倾斜盘等区别会影响临床选择和后续管理。

门诊手术中心、心臟中心和医院的终端使用者细分凸显了不同的采购偏好和服务期望。门诊患者优先考虑效率和吞吐量，而心臟中心和医院则强调全面的护理路径和复杂的病例处理量。根据主动脉瓣、二尖瓣、肺动脉瓣和三尖瓣病变的适应症水平以及主动脉瓣和二尖瓣逆流和狭窄的亚类进行区分，进一步细化了临床需求概况，并决定了器械的外形规格、输送系统和证据生成的优先级。了解这些相互交织的细分轴，製造商和医疗保健系统可以根据手术方法、材料选择和终端用户操作限制的具体需求，客製化产品开发、培训和商业模​​式。

从策略上评估美洲、中东和非洲以及亚太地区的地理差异如何影响临床应用、监管方法和商业策略

区域动态显着影响着人工心臟的开发、核准、采用和支持方式。在美洲，成熟的报销环境和高度集中的先进心臟中心催生了对创新经导管解决方案、整合远端监控和长期设备服务项目的需求。该地区的临床领导者通常透过比较研究和註册参与来推动证据生成，而商业性成功通常取决于强大的临床关係和捆绑式医疗提案。

欧洲、中东和非洲地区的监管和报销格局各不相同，高所得西欧市场与其他注重成本控制的地区在采用模式上有显着差异。在许多欧洲市场，集中采购框架和强大的国家註册体系支持强而有力的上市后监管，而报销体系和卫生技术评估则影响高阶设备的采用率。欧洲、中东和非洲市场表现出来自三级心臟中心和入境医疗旅游的选择性需求，这为专业产品和服务组合创造了利基市场机会。

亚太地区临床能力快速提升，患者数量庞大，国内生产能力不断提升。该地区多个市场正在大力投资微创和经导管项目，并得到当地临床培训计划和伙伴关係的支持。价格敏感性和多元化的支付方结构正在推动生产规模扩大和成本效益更高的设备设计，同时，主要市场的监管机构正在简化途径以促进创新。在整个地区，那些将临床开发、监管策略和上市模式与当地机构奖励和采购规范相结合的公司将找到最永续的采用途径。

关于设备製造商如何利用研究、伙伴关係和服务模式来确保心臟假体市场的领导地位的主要考察

为了维持并扩大竞争地位，心臟假体领域的主要企业正在寻求创新、扩展服务和生态系统伙伴关係关係的结合。研发重点包括下一代瓣叶技术、更细的导管系统、改良的植入式心律管理设备的感测演算法，以及简化植入并减少设备相关併发症的机械设计。在商业性，公司正在投资培训中心、测试网路和长期服务协议，以增强临床忠诚度并产生稳定的售后市场收益。

併购仍然是一个策略性槓桿，能够更快地获得互补技术、製造能力和地理覆盖范围。随着设备製造商寻求提供整合的手术解决方案而非独立的植入，与影像处理公司、数位医疗公司和临床网路的策略联盟变得越来越频繁。同时，新参与企业和专业供应商正在加速对组件和输送系统的竞争，迫使现有企业透过临床证据和供应商支援模式来实现差异化。

在监管机构和医院日益重视器械可追溯性和上市后性能的当下，卓越的製造和品质系统运作仍然是一项不容置疑的能力。那些将产品蓝图与持久的服务生态系统、清晰的报销策略和高效的全球製造相结合的公司，最有可能将其研发投资转化为可持续的商业性回报。

为设备开发商和卫生系统领导者提供可操作的优先建议，以建立有弹性的供应链、证据计划和与付款人一致的商业化策略

行业领导者应优先考虑多维度的方法，在创新、营运韧性和付款人参与之间取得平衡。首先，投资于临床证据项目，这些项目应利用註册资料库、比较有效性试验和真实世界数据，证明患者治疗结果和医疗成本显着改善，从而为临床医生和付款人建立令人信服的叙事。其次，考虑区域製造或双重采购，以加强供应商关係，避免贸易政策波动，并保障医院流程的连续性。

对于门诊手术中心，我们将开发注重手术效率的精简产品；而对于心臟中心和三级医院，我们将设计全面的培训和服务方案。第四，我们将把数位化能力融入我们的设备和患者管理路径，以支持远端随访，及早发现併发症，并为付款人带来可量化的价值。第五，我们将进行有针对性的地理扩张，以加速在重点市场的采用，并将临床培训投资与监管和报销导航相结合。

最后，采取积极主动的方式与监管机构和付款人沟通，预测政策变化并确保获得有利的覆盖途径。透过将研发重点与报销策略和供应链韧性相结合，实施这些建议的公司将能够降低商业化风险并建立永续的竞争优势。

清楚地解释我们的混合调查方法，结合临床医生访谈、监管和临床证据审查以及供应链分析，得出可靠、可行的见解

该研究结合了对心臟外科医生、介入性心臟病专家、采购负责人和设备工程师的专家访谈，以及对监管申报、临床试验註册和同行评审临床文献的系统性回顾，得出了初步结论。该研究对定量和定性输入进行了三角测量，以确定不同产品类型和操作方法的采用驱动因素、临床障碍和营运限制。

为了评估脆弱性和缓解途径，我们利用供应商图谱、进出口趋势评估和采购案例研究，建构了供应链和关税分析。产品细分是透过将产品分类与临床适应症、操作方法和最终用户动态相结合而製定的，确保每个维度都以临床医生的实践模式和医院的运作实际情况为依据。品管包括访谈主题的交叉检验、技术专家的迭代审查（以确保方法学的透明度）以及结论和建议的稳健性。

这种混合方法提供了设备设计、临床实践、管理体制和商业系统如何相互作用的整体视图，提供了可操作的、基于当前临床和操作证据的见解。

总之，我们强调迫切需要协调临床、监管和营运策略，以将创新转化为持续的临床应用和市场弹性。

总而言之，人工心臟领域正处于曲折点，临床创新、程序转型、材料进步和不断发展的商业模式正在汇聚，重塑病患照护路径。将产品开发与严谨的证据产生、灵活的生产策略和支付方参与同步进行，将获得最大价值，并在各种临床环境中持续推广应用。

关税和贸易动态增加了新的营运复杂性，凸显了供应商策略、区域生产决策以及与医疗系统合作伙伴透明沟通的重要性。同时，在地化商业化和临床整合服务模式提供了一条清晰的差异化路径：将研发投资与已证实的临床需求相结合，强化供应链以应对政策变化，并建立必要的实证和商业性基础，将创新转化为改善的患者治疗效果和持续的市场表现。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 以经导管主动脉瓣置换术作为低风险患者族群的标准治疗
  • 将人工智慧和机器学习融入设备开发和病患监测工作流程
  • 3D 列印个人化心臟瓣膜假体的进展，可改善解剖贴合度及治疗效果
  • 经皮二尖瓣修復系统扩大了二尖瓣逆流患者的治疗选择
  • 开发具有更高耐用性和更低钙化率的下一代生物心臟瓣膜
  • 心臟装置植入后患者管理中远端监控和追踪技术的兴起
  • 监管协调和加速核准流程将加速全球心臟假体创新
  • 基于生物工程组织的心臟瓣膜可最大限度地减少血栓形成并消除长期抗凝血治疗的需要
  • 经导管结构性心臟介入治疗的扩展将推动新兴市场的成长
  • 成本效益和基于价值的定价压力不断增加将影响心臟假体设备的采购

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 心臟假体设备市场（依产品类型）

  • 植入式心臟整流去颤器
    • 双腔去心房颤动
    • 单腔去心房颤动
    • 皮下去心房颤动
  • 左心室补助人工心臟
    • 耐用的心室辅助装置
    • 暂时性心室辅助装置
  • 起搏器
    • 双心室节律器
    • 双腔起搏器
    • 单腔起搏器
  • 人工瓣膜
    • 生物瓣膜
    • 机械阀

9. 心臟假体设备市场（依手术方式）

  • 心臟直视手术
    • 微创手术
    • 传统胸骨切开术
  • 经导管
    • 经导管主动脉瓣置换术
    • 经导管二尖瓣置换术

第 10 章：心臟假体装置市场（依材料类型）

  • 生物假体
    • 同种异体移植
    • 异种移植
  • 机器
    • 双叶
    • 斜盘

第 11 章。心臟假体设备市场（依最终用户）

  • 门诊手术中心
  • 心臟中心
  • 医院

第 12 章：心臟假体设备市场（按适应症）

  • 主动脉
    • 回流
    • 收缩
  • 二尖瓣
    • 回流
    • 收缩
  • 肺
  • 三尖瓣

第 13 章：心臟假体设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章心臟假体设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。心臟假体设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Medtronic plc
    • Edwards Lifesciences Corporation
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Johnson & Johnson
    • LivaNova PLC
    • Terumo Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • CryoLife, Inc.
Product Code: MRR-ED54C46E8699

The Cardiac Prosthetic Devices Market is projected to grow by USD 33.24 billion at a CAGR of 16.22% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.98 billion
Estimated Year [2025] USD 11.57 billion
Forecast Year [2032] USD 33.24 billion
CAGR (%) 16.22%

An authoritative introduction to how innovation in device design, clinical practice shifts, and evolving regulatory expectations are redefining cardiac prosthetic device strategy

The field of cardiac prosthetic devices sits at a dynamic intersection of advanced biomedical engineering, evolving clinical practice, and shifting healthcare economics. Over the last decade practitioners and device makers have moved beyond incremental improvements to pursue integrated solutions that combine mechanical reliability, biocompatible materials, and procedural versatility. This evolution reflects growing clinician demand for devices that reduce perioperative risk, shorten recovery time, and improve long-term functional outcomes for increasingly complex patient cohorts.

Regulatory scrutiny and payer expectations have concurrently heightened, requiring manufacturers to generate robust real-world evidence and demonstrate clear value propositions to hospitals and cardiac centers. Supply chain complexity and component specialization have introduced new procurement and manufacturing considerations, prompting original equipment manufacturers to rethink supplier relationships and vertical capabilities. As a result, strategy discussions among executive teams now routinely consider not only product design but also evidence generation, service models, and lifecycle economics.

Looking ahead, opportunities for differentiation will center on convergent innovations: miniaturized electronics, advanced polymer and tissue solutions, device durability enhancements, and procedural approaches that favor less invasive access. Stakeholders who align clinical evidence plans, regulatory pathways, and commercialization tactics will be best positioned to translate scientific promise into sustained clinical adoption and long-term commercial success.

A forward looking synthesis of radical procedural innovations, materials advances, and commercial realignments that are reshaping the cardiac prosthetic device ecosystem

The cardiac prosthetic landscape is undergoing a set of transformative shifts that are remapping competitive advantage and clinical practice. Transcatheter techniques, propelled by advances in catheter delivery systems and imaging, are expanding indications previously handled via open cardiac surgery and enabling treatment of higher-risk patients. At the same time, device miniaturization and the integration of sensing and connectivity into implantable platforms are enabling remote monitoring, adaptive therapy algorithms, and closer alignment with value-based care models.

Materials science has introduced longer-lasting biological and synthetic options that reduce thrombogenicity and improve hemodynamic performance, while manufacturing innovations such as additive manufacturing and precision machining are enabling more complex geometries and tailored device footprints. Health systems are placing greater emphasis on total cost of care, driving device strategies that emphasize procedural efficiency, reduced length of stay, and lower complication rates. Finally, collaborative models between device companies, clinical centers, and payers are becoming more common, with shared data initiatives and risk-sharing agreements accelerating evidence generation and reimbursement alignment.

These shifts are not uniform across geographies or clinical settings, but together they are raising the bar for entrants and incumbents alike: success will depend on integrating clinical, regulatory, and commercial threads into coherent programs that can demonstrate patient benefit and economic rationale in real-world practice.

An in depth analysis of how evolving United States trade measures are cumulatively reshaping procurement, manufacturing footprints, and clinical access across cardiac prosthetic supply chains

Evolving trade measures originating from recent policy adjustments in the United States have introduced a set of cumulative effects across procurement, manufacturing, and clinical supply chains for cardiac prosthetic devices. The immediate impact has been higher landed costs for certain imported components, prompting device manufacturers and distributors to reassess supplier contracts and inventory strategies. In response, many organizations have accelerated supplier diversification, dual-sourcing strategies, and regional inventory buffers to protect operating room schedules and reduce exposure to single-source disruptions.

Beyond short-term pricing pressure, these trade dynamics are influencing strategic decisions around manufacturing footprint and capital allocation. Some manufacturers are evaluating near-shoring options or investing in additional domestic capabilities to mitigate tariff risk and shorten lead times for critical components. These shifts carry implications for cost structures and unit economics, but they also offer potential resilience benefits that can be essential in maintaining clinical supply continuity.

Clinicians and hospital procurement teams are increasingly focused on total cost of care rather than unit price alone, factoring in device reliability, service coverage, and procedure throughput when selecting suppliers. Regulatory bodies and payers are watching these changes closely, as supply chain reconfiguration can affect device availability and continuity of care. Ultimately, stakeholders that proactively model tariff-driven scenarios, engage suppliers in collaborative cost-management, and communicate effectively with health systems will be better equipped to safeguard both margins and patient access as trade policy evolves.

Comprehensive segmentation insight revealing how product type, procedure approach, material selection, end user needs, and clinical indication intersect to shape commercial and clinical strategies

A nuanced segmentation view reveals where clinical demand, procedural choice, and material science converge to drive differentiated opportunities. When examining the market by product type, implantable cardioverter defibrillators present distinct subcategories including dual chamber, single chamber, and subcutaneous systems, each with unique clinical use cases and technology requirements. Left ventricular assist devices divide into durable and temporary solutions, reflecting divergent patient populations and service models. Pacemakers include biventricular, dual chamber, and single chamber devices, where pacing modality and programming complexity influence follow-up care and remote monitoring needs. Valve prostheses are split between bioprosthetic and mechanical options, with bioprosthetic valves further characterized by homograft and xenograft derivations, and mechanical valves differentiated by bileaflet and tilting disc designs, all of which carry implications for durability, anticoagulation management, and patient counseling.

Approach to procedure further stratifies adoption pathways: open heart surgery remains relevant where anatomical considerations or complex repair are necessary, with subvariants such as minimally invasive surgery and traditional sternotomy shaping hospital resource utilization. The transcatheter route, encompassing aortic and mitral valve replacement approaches, has expanded access to interventions for older or higher-risk patients and is driving investment in catheter design and imaging support. Material type continues to be a defining axis, with bioprosthetic options offering favorable hemodynamics and biological integration and mechanical choices providing long term durability; within these classes, distinctions such as homograft versus xenograft or bileaflet versus tilting disc inform both clinical selection and downstream management.

End user segmentation across ambulatory surgical centers, cardiac centers, and hospitals highlights diverse procurement preferences and service expectations, with ambulatory settings prioritizing efficiency and throughput while cardiac centers and hospitals emphasize comprehensive care pathways and complex case capabilities. Indication-level differentiation across aortic, mitral, pulmonary, and tricuspid lesions, and subcategories of regurgitation and stenosis for aortic and mitral pathologies, further refines clinical demand profiles, informing device form factors, delivery systems, and evidence generation priorities. Understanding these intersecting segmentation axes allows manufacturers and health systems to tailor product development, training, and commercial models to the specific needs of procedural approaches, material choices, and end user operational constraints.

A strategic assessment of how geographic differences across the Americas, Europe Middle East and Africa, and Asia Pacific shape clinical adoption, regulatory approach, and commercial strategy

Regional dynamics materially influence how cardiac prosthetic devices are developed, approved, adopted, and supported. In the Americas, a mature reimbursement environment and a high concentration of advanced cardiac centers create demand for innovative transcatheter solutions, integrated remote monitoring, and long-term device service programs. Clinical leaders in this region often drive evidence generation through comparative studies and registry participation, and commercial success typically hinges on strong clinical relationships and bundled care propositions.

The Europe, Middle East & Africa region presents a heterogeneous regulatory and reimbursement landscape where adoption patterns vary significantly between high-income Western European markets and other jurisdictions that may prioritize cost containment. In many European markets, centralized procurement frameworks and strong national registries support robust post-market surveillance, while reimbursement mechanisms and health technology assessment influence the speed of uptake for premium devices. Middle Eastern and African markets show selective demand driven by tertiary cardiac centers and inbound medical travel, creating niche opportunities for specialized products and service bundles.

Asia-Pacific combines rapidly expanding clinical capacity with large patient volumes and growing domestic manufacturing capabilities. Several markets in the region are investing heavily in minimally invasive and transcatheter programs, supported by local clinical training initiatives and partnerships. Pricing sensitivity and diverse payer structures encourage scaled manufacturing and cost-effective device designs, while regulatory authorities in leading markets are streamlining pathways to encourage innovation. Across regions, companies that align clinical development, regulatory strategy, and go-to-market models to local system incentives and procurement norms will find the most durable routes to adoption.

Key competitive and operational insights into how device manufacturers are leveraging research, partnerships, and service models to secure leadership in cardiac prosthetic markets

Leading companies in the cardiac prosthetic arena are pursuing a mix of innovation, service expansion, and ecosystem partnerships to protect and extend competitive positions. R&D focus areas include next-generation valve leaflet technology, low-profile catheter systems, improved sensing algorithms for implantable rhythm management devices, and mechanical designs that simplify implantation or reduce device-related complications. Commercially, companies are investing in training centers, proctoring networks, and long-term service contracts that reinforce clinical loyalty and generate steady aftermarket revenue.

Mergers and acquisitions continue to be a strategic lever, enabling rapid access to complementary technologies, manufacturing capacity, and regional footprints. Strategic alliances with imaging companies, digital health firms, and clinical networks are becoming more frequent as device makers seek to deliver integrated procedural solutions rather than stand-alone implants. At the same time, new entrants and specialized suppliers are accelerating competition in components and delivery systems, compelling incumbents to sharpen differentiation through clinical evidence and provider support models.

Operational excellence in manufacturing and quality systems remains a non-negotiable competency, particularly as regulators and hospitals emphasize device traceability and post-market performance. Firms that align product roadmaps with durable service ecosystems, clear reimbursement strategies, and efficient global manufacturing will be best placed to convert R&D investment into sustained commercial returns.

Actionable and prioritized recommendations for device developers and health system leaders to build resilient supply chains, evidence programs, and payer aligned commercialization strategies

Industry leaders should prioritize a multidimensional approach that balances innovation with operational resilience and payer engagement. First, invest in clinical evidence programs that demonstrate meaningful improvements in patient outcomes and cost of care, using registries, comparative effectiveness studies, and real-world data to build compelling narratives for clinicians and payers. Second, strengthen supplier relationships and consider regional manufacturing or dual sourcing to hedge against trade policy volatility and protect procedural continuity in hospitals.

Third, align commercial models with how end users purchase and deploy devices: develop streamlined offerings for ambulatory surgical centers that emphasize procedural efficiency, while designing comprehensive training and service packages for cardiac centers and tertiary hospitals. Fourth, integrate digital capabilities into devices and patient management pathways to support remote follow-up, detect complications early, and provide quantifiable value to payers. Fifth, pursue targeted geographic expansion that pairs clinical training investments with regulatory and reimbursement navigation to accelerate uptake in priority markets.

Finally, adopt a proactive regulatory and payer engagement posture that anticipates policy changes and secures favorable coverage pathways. Companies that operationalize these recommendations-by connecting R&D priorities to reimbursement strategies and supply chain resilience-will reduce commercialization risk and build sustainable competitive advantage.

A clear explanation of the blended research approach combining clinician interviews, regulatory and clinical evidence review, and supply chain analysis to ensure robust actionable insights

This research synthesizes primary insights from expert interviews with cardiac surgeons, interventional cardiologists, procurement leaders, and device engineers, combined with a systematic review of regulatory filings, clinical trial registries, and peer reviewed clinical literature. Quantitative and qualitative inputs were triangulated to identify adoption drivers, clinical barriers, and operational constraints across product types and procedural approaches.

Supply chain and tariff analyses were constructed using supplier mapping, import-export trend reviews, and procurement case studies to assess vulnerability and mitigation pathways. Segmentation was developed by aligning product taxonomies with clinical indications, procedural approaches, and end user dynamics, ensuring that each axis was informed by clinician practice patterns and hospital operational realities. Quality control included cross-validation of interview themes, methodological transparency, and iterative review with technical experts to ensure the robustness of conclusions and recommendations.

This blended methodology enables a holistic view of how device design, clinical practice, regulatory regimes, and commercial systems interact, producing insights that are both actionable and grounded in current clinical and operational evidence.

A concluding synthesis emphasizing the urgency for coordinated clinical, regulatory, and operational strategies to convert innovation into sustained clinical adoption and market resilience

In conclusion, the cardiac prosthetic device landscape is at an inflection point where clinical innovation, procedural migration, material advancements, and commercial model evolution are converging to reshape patient care pathways. Organizations that synchronize product development with rigorous evidence generation, resilient manufacturing strategies, and payer engagement will capture the greatest value and sustain adoption across diverse clinical settings.

Tariff and trade dynamics add a new layer of operational complexity that amplifies the importance of supplier strategy, regional manufacturing decisions, and transparent communication with health system partners. At the same time, regionally tailored commercialization and clinically integrated service models offer clear routes to differentiation. The imperative for leaders is to act decisively: align R&D investment to proven clinical needs, fortify supply chains against policy shifts, and build the evidentiary and commercial scaffolding required to translate innovation into improved patient outcomes and durable market performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of transcatheter aortic valve replacement in low-risk patient populations as standard of care
  • 5.2. Integration of artificial intelligence and machine learning into device development and patient monitoring workflows
  • 5.3. Advancements in 3D printed personalized cardiac prosthetic valves for improved anatomical fit and outcomes
  • 5.4. Emergence of percutaneous mitral valve repair systems expanding treatment options for mitral regurgitation patients
  • 5.5. Development of next-generation bioprosthetic heart valves with enhanced durability and reduced calcification rates
  • 5.6. Rise of telemonitoring and remote follow-up technologies for post-implant cardiac device patient management
  • 5.7. Regulatory harmonization and fast-track approval pathways accelerating cardiac prosthetic device innovations globally
  • 5.8. Bioengineering of tissue-based heart valves to minimize thrombogenicity and eliminate long-term anticoagulation requirements
  • 5.9. Expansion of transcatheter structural heart interventions driving market growth in emerging economies
  • 5.10. Increasing cost-effectiveness and value-based pricing pressures shaping procurement of cardiac prosthetic devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Prosthetic Devices Market, by Product Type

  • 8.1. Implantable Cardioverter Defibrillators
    • 8.1.1. Dual Chamber Defibrillators
    • 8.1.2. Single Chamber Defibrillators
    • 8.1.3. Subcutaneous Defibrillators
  • 8.2. Left Ventricular Assist Devices
    • 8.2.1. Durable Ventricular Assist Devices
    • 8.2.2. Temporary Ventricular Assist Devices
  • 8.3. Pacemakers
    • 8.3.1. Biventricular Pacemakers
    • 8.3.2. Dual Chamber Pacemakers
    • 8.3.3. Single Chamber Pacemakers
  • 8.4. Valve Prostheses
    • 8.4.1. Bioprosthetic Valves
    • 8.4.2. Mechanical Valves

9. Cardiac Prosthetic Devices Market, by Procedure Approach

  • 9.1. Open Heart Surgery
    • 9.1.1. Minimally Invasive Surgery
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter
    • 9.2.1. Transcatheter Aortic Valve Replacement
    • 9.2.2. Transcatheter Mitral Valve Replacement

10. Cardiac Prosthetic Devices Market, by Material Type

  • 10.1. Bioprosthetic
    • 10.1.1. Homograft
    • 10.1.2. Xenograft
  • 10.2. Mechanical
    • 10.2.1. Bileaflet
    • 10.2.2. Tilting Disc

11. Cardiac Prosthetic Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Cardiac Prosthetic Devices Market, by Indication

  • 12.1. Aortic
    • 12.1.1. Regurgitation
    • 12.1.2. Stenosis
  • 12.2. Mitral
    • 12.2.1. Regurgitation
    • 12.2.2. Stenosis
  • 12.3. Pulmonary
  • 12.4. Tricuspid

13. Cardiac Prosthetic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Prosthetic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Prosthetic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Edwards Lifesciences Corporation
    • 16.3.3. Abbott Laboratories
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Johnson & Johnson
    • 16.3.6. LivaNova PLC
    • 16.3.7. Terumo Corporation
    • 16.3.8. Biotronik SE & Co. KG
    • 16.3.9. MicroPort Scientific Corporation
    • 16.3.10. CryoLife, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CARDIAC PROSTHETIC DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CARDIAC PROSTHETIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC PROSTHETIC DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-202